Home > > > > > > Report Detail

AIDS Related Kaposi's Sarcoma - Epidemiology Forecast to 2028

Publisher Name :
Date: 15-Jan-2019
No. of pages: 50
Delivery of the Report will take 2-3 working days once order is placed.

DelveInsight's "AIDS Related Kaposi's Sarcoma - Epidemiology Forecast, 2028" report provides a comprehensive analysis of the AIDS Related Kaposi's Sarcoma epidemiology, providing the historical and forecasted data for the 7MM during the forecast period from 2016-2028.

Markets Covered

- United States

- EU5 (Germany, France, Italy, Spain, and the United Kingdom)

- Japan

Study Period: 2016-2028

AIDS Related Kaposi's Sarcoma Epidemiology

The epidemiology section covers the historical, current as well as forecasted epidemiology for AIDS Related Kaposi's Sarcoma in 7 major markets. The data is collected by understanding the disease, reviewing numerous studies conducted by countries and by exploring different surveys as well as reports. The Key opinion leaders' views are also taken into account to provide a deep understanding of the AIDS Related Kaposi's Sarcoma outlook. It also includes the explanation of changing trends of epidemiology outlining the AIDS Related Kaposi's Sarcoma scenario.

AIDS Related Kaposi's Sarcoma Epidemiology Segmentation

The epidemiology section is further segmented according to the patient pool characteristics, such as age-specific, type-specific, sub-type specific, gender-specific etc., thus providing an in-depth and high-quality analysis. The report also covers the prevalent/Incidence cases as well as the treatable cases as per the therapies available for the AIDS Related Kaposi's Sarcoma thereby presenting the trends with detailed analysis, with the assumptions undertaken. The data is presented in the form of graphs along with tables to effectively summarize the landscape.

Report Scope

- The report covers detailed overview of AIDS Related Kaposi's Sarcoma explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns

- It provides the insight about the historical and forecasted patient pool for 7 major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan

- The AIDS Related Kaposi's Sarcoma Report assesses the disease risk and burden and highlights the unmet needs

- It also helps to recognize the growth opportunities in the 7MM with respect to the patient population

Key strengths

- 10 Year Forecast

- 7MM Coverage

- Total Cases in AIDS Related Kaposi's Sarcoma

Key assessments

- Patient Segmentation in AIDS Related Kaposi's Sarcoma

- AIDS Related Kaposi's Sarcoma Risk & Burden

- Factors driving growth in a specific AIDS Related Kaposi's Sarcoma patient population

AIDS Related Kaposi's Sarcoma - Epidemiology Forecast to 2028

Table of Contents

1. Report Introduction
2. AIDS Related Kaposi's Sarcoma Epidemiology Overview at a Glance
2.1. Patient Share Distribution of AIDS Related Kaposi's Sarcoma in 2016
2.2. Patient Share Distribution of AIDS Related Kaposi's Sarcoma in 2028
3. Disease Background and Overview: AIDS Related Kaposi's Sarcoma
3.1. Introduction
3.2. Symptoms
3.3. Etiology
3.4. Risk Factors
3.5. Pathophysiology
3.6. Diagnosis
3.7. Treatment
4. Epidemiology and Patient Population
4.1. Key Findings
4.2. Total Prevalent/ Incident Patient Population of AIDS Related Kaposi's Sarcoma in 7MM
4.3. Total Prevalent/ Incident Patient Population of AIDS Related Kaposi's Sarcoma in 7MM - By Countries
5. Epidemiology of AIDS Related Kaposi's Sarcoma by Countries
5.1. United States
5.1.1. Assumptions and Rationale
5.1.2. Prevalent/Incident Cases of the AIDS Related Kaposi's Sarcoma
5.1.3. Sub-Type Specific cases of the AIDS Related Kaposi's Sarcoma *
5.1.4. Sex- Specific Cases of the AIDS Related Kaposi's Sarcoma*
5.1.5. Diagnosed Cases of the AIDS Related Kaposi's Sarcoma
5.2. EU5
5.3. Assumptions and Rationale
5.4. Germany
5.4.1. Assumptions and Rationale
5.4.2. Prevalent/Incident Cases of the AIDS Related Kaposi's Sarcoma
5.4.3. Sub-Type Specific cases of the AIDS Related Kaposi's Sarcoma*
5.4.4. Sex- Specific Cases of the AIDS Related Kaposi's Sarcoma*
5.4.5. Diagnosed Cases of the AIDS Related Kaposi's Sarcoma
5.5. France
5.5.1. Assumptions and Rationale
5.5.2. Prevalent/Incident Cases of the AIDS Related Kaposi's Sarcoma
5.5.3. Sub-Type Specific cases of the AIDS Related Kaposi's Sarcoma*
5.5.4. Sex- Specific Cases of the AIDS Related Kaposi's Sarcoma*
5.5.5. Diagnosed Cases of the AIDS Related Kaposi's Sarcoma
5.6. Italy
5.6.1. Assumptions and Rationale
5.6.2. Prevalent/Incident Cases of the AIDS Related Kaposi's Sarcoma
5.6.3. Sub-Type Specific cases of the AIDS Related Kaposi's Sarcoma*
5.6.4. Sex- Specific Cases of the AIDS Related Kaposi's Sarcoma*
5.6.5. Diagnosed Cases of the AIDS Related Kaposi's Sarcoma
5.7. Spain
5.7.1. Assumptions and Rationale
5.7.2. Prevalent/Incident Cases of the AIDS Related Kaposi's Sarcoma
5.7.3. Sub-Type Specific cases of the AIDS Related Kaposi's Sarcoma*
5.7.4. Sex- Specific Cases of the AIDS Related Kaposi's Sarcoma*
5.7.5. Diagnosed Cases of the AIDS Related Kaposi's Sarcoma
5.8. United Kingdom
5.8.1. Assumptions and Rationale
5.8.2. Prevalent/Incident Cases of the AIDS Related Kaposi's Sarcoma
5.8.3. Sub-Type Specific cases of the AIDS Related Kaposi's Sarcoma*
5.8.4. Sex- Specific Cases of the AIDS Related Kaposi's Sarcoma*
5.8.5. Diagnosed Cases of the AIDS Related Kaposi's Sarcoma
5.9. Japan
5.9.1. Assumptions and Rationale
5.9.2. Prevalent/Incident Cases of the AIDS Related Kaposi's Sarcoma
5.9.3. Sub-Type Specific cases of the AIDS Related Kaposi's Sarcoma*
5.9.4. Sex- Specific Cases of the AIDS Related Kaposi's Sarcoma*
5.9.5. Diagnosed Cases of the AIDS Related Kaposi's Sarcoma
6. Unmet Needs of the AIDS Related Kaposi's Sarcoma
7. Appendix
8. Report Methodology
8.1. Sources
9. DelveInsight Capabilities
10. Disclaimer
11. About DelveInsight
*Indication Specific

List of Tables

Table 1: Total Prevalent/Incident Cases of the AIDS Related Kaposi's Sarcoma in 7MM
Table 2: Total Prevalent/Incident Cases of the AIDS Related Kaposi's Sarcoma in 7MM by Countries
Table 3: Prevalent/Incident Cases of the AIDS Related Kaposi's Sarcoma in United States (2016-2028)
Table 4: Sub-Type Specific cases of the AIDS Related Kaposi's Sarcoma in United States (2016-2028)*
Table 5: Sex- Specific Cases of the AIDS Related Kaposi's Sarcoma in United States (2016-2028)*
Table 6: Diagnosed Cases of the AIDS Related Kaposi's Sarcoma in United States (2016-2028)
Table 7: Prevalent/Incident Cases of the AIDS Related Kaposi's Sarcoma in Germany (2016-2028)
Table 8: Sub-Type Specific cases of the AIDS Related Kaposi's Sarcoma in Germany (2016-2028) *
Table 9: Sex- Specific Cases of the AIDS Related Kaposi's Sarcoma in Germany (2016-2028) *
Table 10: Diagnosed Cases of the AIDS Related Kaposi's Sarcoma in Germany (2016-2028)
Table 11: Prevalent/Incident Cases of the AIDS Related Kaposi's Sarcoma in France (2016-2028)
Table 12: Sub-Type Specific cases of the AIDS Related Kaposi's Sarcoma in France (2016-2028) *
Table 13: Sex- Specific Cases of the AIDS Related Kaposi's Sarcoma in France (2016-2028) *
Table 14: Diagnosed Cases of the AIDS Related Kaposi's Sarcoma in France (2016-2028)
Table 15: Prevalent/Incident Cases of the AIDS Related Kaposi's Sarcoma in Italy (2016-2028)
Table 16: Sub-Type Specific cases of the AIDS Related Kaposi's Sarcoma in Italy (2016-2028) *
Table 17: Sex- Specific Cases of the AIDS Related Kaposi's Sarcoma in Italy (2016-2028) *
Table 18: Diagnosed Cases of the AIDS Related Kaposi's Sarcoma in Italy (2016-2028)
Table 19: Prevalent/Incident Cases of the AIDS Related Kaposi's Sarcoma in Spain (2016-2028)
Table 20: Sub-Type Specific cases of the AIDS Related Kaposi's Sarcoma in Spain (2016-2028) *
Table 21: Sex- Specific Cases of the AIDS Related Kaposi's Sarcoma in Spain (2016-2028) *
Table 22: Diagnosed Cases of the AIDS Related Kaposi's Sarcoma in Spain (2016-2028)
Table 23: Prevalent/Incident Cases of the AIDS Related Kaposi's Sarcoma in UK (2016-2028)
Table 24: Sub-Type Specific cases of the AIDS Related Kaposi's Sarcoma in UK (2016-2028) *
Table 25: Sex- Specific Cases of the AIDS Related Kaposi's Sarcoma in UK (2016-2028) *
Table 26: Diagnosed Cases of the AIDS Related Kaposi's Sarcoma in UK (2016-2028)
Table 27: Prevalent/Incident Cases of the AIDS Related Kaposi's Sarcoma in Japan (2016-2028)
Table 28: Sub-Type Specific cases of the AIDS Related Kaposi's Sarcoma in Japan (2016-2028) *
Table 29: Sex- Specific Cases of the AIDS Related Kaposi's Sarcoma in Japan (2016-2028) *
Table 30: Diagnosed Cases of the AIDS Related Kaposi's Sarcoma in Japan (2016-2028)

List of Figures

Figure 1: Total Prevalent/Incident Cases of the AIDS Related Kaposi's Sarcoma in 7MM
Figure 2: Total Prevalent/Incident Cases of the AIDS Related Kaposi's Sarcoma in 7MM by Countries
Figure 3: Prevalent/Incident Cases of the AIDS Related Kaposi's Sarcoma in United States (2016-2028)
Figure 4: Sub-Type Specific cases of the AIDS Related Kaposi's Sarcoma in United States (2016-2028)*
Figure 5: Sex- Specific Cases of the AIDS Related Kaposi's Sarcoma in United States (2016-2028)*
Figure 6: Diagnosed Cases of the AIDS Related Kaposi's Sarcoma in United States (2016-2028)
Figure 7: Prevalent/Incident Cases of the AIDS Related Kaposi's Sarcoma in Germany (2016-2028)
Figure 8: Sub-Type Specific cases of the AIDS Related Kaposi's Sarcoma in Germany (2016-2028) *
Figure 9: Sex- Specific Cases of the AIDS Related Kaposi's Sarcoma in Germany (2016-2028) *
Figure 10: Diagnosed Cases of the AIDS Related Kaposi's Sarcoma in Germany (2016-2028)
Figure 11: Prevalent/Incident Cases of the AIDS Related Kaposi's Sarcoma in France (2016-2028)
Figure 12: Sub-Type Specific cases of the AIDS Related Kaposi's Sarcoma in France (2016-2028) *
Figure 13: Sex- Specific Cases of the AIDS Related Kaposi's Sarcoma in France (2016-2028) *
Figure 14: Diagnosed Cases of the AIDS Related Kaposi's Sarcoma in France (2016-2028)
Figure 15: Prevalent/Incident Cases of the AIDS Related Kaposi's Sarcoma in Italy (2016-2028)
Figure 16: Sub-Type Specific cases of the AIDS Related Kaposi's Sarcoma in Italy (2016-2028) *
Figure 17: Sex- Specific Cases of the AIDS Related Kaposi's Sarcoma in Italy (2016-2028) *
Figure 18: Diagnosed Cases of the AIDS Related Kaposi's Sarcoma in Italy (2016-2028)
Figure 19: Prevalent/Incident Cases of the AIDS Related Kaposi's Sarcoma in Spain (2016-2028)
Figure 20: Sub-Type Specific cases of the AIDS Related Kaposi's Sarcoma in Spain (2016-2028) *
Figure 21: Sex- Specific Cases of the AIDS Related Kaposi's Sarcoma in Spain (2016-2028) *
Figure 22: Diagnosed Cases of the AIDS Related Kaposi's Sarcoma in Spain (2016-2028)
Figure 23: Prevalent/Incident Cases of the AIDS Related Kaposi's Sarcoma in UK (2016-2028)
Figure 24: Sub-Type Specific cases of the AIDS Related Kaposi's Sarcoma in UK (2016-2028) *
Figure 25: Sex- Specific Cases of the AIDS Related Kaposi's Sarcoma in UK (2016-2028) *
Figure 26: Diagnosed Cases of the AIDS Related Kaposi's Sarcoma in UK (2016-2028)
Figure 27: Prevalent/Incident Cases of the AIDS Related Kaposi's Sarcoma in Japan (2016-2028)
Figure 28: Sub-Type Specific cases of the AIDS Related Kaposi's Sarcoma in Japan (2016-2028) *
Figure 29: Sex- Specific Cases of the AIDS Related Kaposi's Sarcoma in Japan (2016-2028) *
Figure 30: Diagnosed Cases of the AIDS Related Kaposi's Sarcoma in Japan (2016-2028)

  • Global Abacavir Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 02-Jan-2024        Price: US 3380 Onwards        Pages: 106
    Market Overview of Global Abacavir market: According to our latest research, the global Abacavir market looks promising in the next 5 years. As of 2022, the global Abacavir market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Abacavir market, with a systematical descriptio......
  • Global Abacavir Market Research Report 2023
    Published: 05-Dec-2023        Price: US 2900 Onwards        Pages: 85
    This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Abacavir market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - GSK - Aurobindo - Novnauki - Smilax - Hycultec - Atripla Segment by Type - Tablet Abacavir - Oral Solution Abacavir S......
  • Global Zidovudine Market Research Report 2023, Forecast to 2028
    Published: 22-Nov-2023        Price: US 2680 Onwards        Pages: 136
    Zidovudine is used along with other medications to treat human immunodeficiency virus (HIV) infection. Zidovudine is given to HIV-positive pregnant women to reduce the chance of passing the infection to the baby. Zidovudine is in a class of medications called nucleoside reverse transcriptase inhibitors (NRTIs). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (m......
  • Global Zidovudine Professional Survey Report 2023, Forecast to 2028
    Published: 22-Nov-2023        Price: US 3280 Onwards        Pages: 104
    Zidovudine is used along with other medications to treat human immunodeficiency virus (HIV) infection. Zidovudine is given to HIV-positive pregnant women to reduce the chance of passing the infection to the baby. Zidovudine is in a class of medications called nucleoside reverse transcriptase inhibitors (NRTIs). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (m......
  • Global Abacavir Sulfate Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 29-Aug-2023        Price: US 3380 Onwards        Pages: 127
    Market Overview of Global Abacavir Sulfate market: According to our latest research, the global Abacavir Sulfate market looks promising in the next 5 years. As of 2022, the global Abacavir Sulfate market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Abacavir Sulfate market......
  • Global Zidovudine Market Insights, Forecast to 2029
    Published: 29-Aug-2023        Price: US 4900 Onwards        Pages: 75
    Zidovudine (ZDV), also known as azidothymidine (AZT), is an antiretroviral medication used to prevent and treat HIV/AIDS. It is generally recommended for use with other antiretrovirals. It may be used to prevent mother-to-child spread during birth or after a needlestick injury or other potential exposure. It is sold both by itself and together as lamivudine/zidovudine and abacavir/lamivudine/zidovudine. It can be used by mouth or by slow injection into a vein. The global Zidovudin......
  • Global HIV Drugs Market Insights, Forecast to 2029
    Published: 14-Aug-2023        Price: US 4900 Onwards        Pages: 93
    HIV is a type of retrovirus that causes serious complications in humans. It generally spreads via the blood, semen, vaginal fluid, pre-ejaculate, or breast milk. The global market for HIV drugs is envisaged to surpass USD 19,000 million by 2019 owing to the recent rise in HIV patient population. The global HIV Drugs market is projected to grow from US$ 23910 million in 2023 to US$ 26950 million by 2029, at a Compound Annual Growth Rate (CAGR) of 2.0% during the forecast period.......
  • HIV Treatment Drugs Industry Forecasts - China Focus
    Published: 24-Jul-2023        Price: US 1800 Onwards        Pages: 91
    This study focuses on China's HIV Treatment Drugs industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China's society and economy. China is one of the world's major producers for industrial and consumer products. Far outpacing other economies in the world, China is the world's fastest growing market for the consumptions of goods and services.......
  • HIV Treatment Drugs Markets in China
    Published: 24-Jul-2023        Price: US 4000 Onwards        Pages: 225
    China's demand for HIV Treatment Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, ind......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs